本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Solid Biosciences

4.58
+0.24005.53%
成交量:66.99万
成交额:301.78万
市值:3.57亿
市盈率:-2.04
高:4.73
开:4.27
低:4.24
收:4.34
52周最高:7.37
52周最低:2.41
股本:7,791.02万
流通股本:3,761.32万
量比:0.71
换手率:1.78%
股息:- -
股息率:- -
每股收益(TTM):-2.2440
每股收益(LYR):-3.0550
净资产收益率:-86.83%
总资产收益率:-43.67%
市净率:1.64
市盈率(LYR):-1.50

数据加载中...

2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/20

重要事件披露

8-K - Current report